VCYT
VCYT
NASDAQ · Biotechnology

Veracyte Inc

$53.63
+2.34 (+4.56%)
As of Jun 21, 9:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
512.13M
Net Income
65.71M
Gross Margin
70.1%
Profit Margin
12.8%
Rev Growth
+20.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 512.13M 425.47M 507.99M 466.85M
Gross Profit 359.01M 298.25M 340.77M 313.18M
Operating Income 57.21M 42.77M -2,427,180 -2,364,906
Net Income 65.71M 49.13M -2,027,984 -2,410,114
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Rev Growth +20.4% +20.4% +16.6% +7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 875.10M 761.72M
Total Equity 1.67B 1.94B
D/E Ratio 0.52 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 65.05M 51.34M -2,983,128 -2,794,572
Free Cash Flow -1,866,923 -2,624,091